Clinical Takeaway GLP-1 receptor agonists, the drug class that includes medications like semaglutide, were studied using genetic analysis to assess their causal effect on ten psychiatric conditions. The findings suggest these medications...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In this rigorous crossover trial, neither a low nor a high single dose of CBD directly altered cortical excitability or produced measurable sedation in healthy adults. This suggests that CBD’s...
`Cannabinoids for Children: Clinical Evidence Reviewed`
Clinical Takeaway Current evidence on cannabinoids in pediatric patients spans 276 studies across multiple designs, capturing both plant-derived and pharmaceutical formulations used to treat medical conditions in children under 18. The research...
`Cannabinoid Clinical Trials: Cannabis for Chronic Back Pain`
Clinical Takeaway In this phase 3 randomized controlled trial, 820 adults with chronic low back pain received either VER-01, a full-spectrum cannabis extract, or placebo over 12 weeks, with longer-term follow-up extending...
Endocannabinoid System Research: Cannabis for Chronic Pain
Clinical Takeaway Clinical trials show that cannabis-based products containing THC provide modest reductions in chronic pain compared to placebo, though the overall strength of evidence remains low to moderate. Products vary considerably...